Smith Competitors
| SNN Stock | USD 36.36 0.39 1.06% |
Smith Nephew vs Neurocrine Biosciences Correlation
Excellent diversification
The correlation between Smith Nephew SNATS and NBIX is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and NBIX in the same portfolio, assuming nothing else is changed.
Moving against Smith Stock
| 0.9 | IPD | Impedimed | PairCorr |
| 0.83 | 56S1 | Sartorius Stedim Biotech | PairCorr |
| 0.83 | 56S0 | RENAUUNSPARD 15 EO | PairCorr |
| 0.72 | SI | Shoulder Innovations Earnings Call This Week | PairCorr |
| 0.68 | IL3 | Integra LifeSciences | PairCorr |
Smith Nephew Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Smith Nephew and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Smith and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Smith Nephew SNATS does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Smith Stock performing well and Smith Nephew Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Smith Nephew's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HOLX | 0.13 | 0.00 | (0.22) | 0.11 | 0.10 | 0.25 | 0.75 | |||
| ZBH | 1.09 | (0.01) | (0.01) | 0.03 | 1.32 | 2.22 | 7.13 | |||
| FMS | 1.33 | (0.05) | 0.00 | (0.10) | 0.00 | 3.04 | 11.46 | |||
| MEDP | 1.69 | (0.41) | 0.00 | (0.49) | 0.00 | 3.02 | 19.65 | |||
| RPRX | 0.84 | 0.27 | 0.23 | 1.08 | 0.74 | 2.01 | 5.26 | |||
| TEM | 2.79 | (0.63) | 0.00 | (0.30) | 0.00 | 5.61 | 14.80 | |||
| COO | 1.08 | 0.16 | 0.09 | (0.49) | 1.09 | 2.50 | 9.80 | |||
| CNC | 1.78 | 0.15 | 0.05 | 0.23 | 2.47 | 4.46 | 17.20 | |||
| THC | 1.47 | 0.18 | 0.10 | 1.66 | 1.26 | 3.14 | 19.04 | |||
| NBIX | 1.38 | (0.15) | 0.00 | (0.19) | 0.00 | 2.38 | 16.04 |
Cross Equities Net Income Analysis
Compare Smith Nephew SNATS and related stocks such as Hologic, Zimmer Biomet Holdings, and Fresenius Medical Care Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOLX | 1.4 M | (73.6 M) | (1.2 B) | 17.3 M | 131.6 M | 330.8 M | 755.5 M | (111.3 M) | (40.2 M) | 1.1 B | 1.9 B | 1.3 B | 456 M | 789.5 M | 565.7 M | 650.6 M | 683.1 M |
| ZBH | 145 M | 760.8 M | 755 M | 761 M | 720.3 M | 147 M | 305.9 M | 1.8 B | (379.2 M) | 1.1 B | (138.9 M) | 401.6 M | 231.4 M | 1 B | 903.8 M | 705.2 M | 605.5 M |
| FMS | 82 M | 826.4 M | 897.4 M | 803.8 M | 859.4 M | 941.2 M | 1.2 B | 1.3 B | 2 B | 1.2 B | 1.2 B | 969.3 M | 673.4 M | 499 M | 537.9 M | 978 M | 720.9 M |
| MEDP | 24.8 M | 24.8 M | 24.8 M | 24.8 M | (15.6 M) | (8.7 M) | 13.4 M | 39.1 M | 73.2 M | 100.4 M | 145.4 M | 181.8 M | 245.4 M | 282.8 M | 404.4 M | 451.1 M | 473.7 M |
| RPRX | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | 581.4 M | 565.9 M | 1.2 B | 1.4 B | 2.3 B | 975 M | 619.7 M | 42.8 M | 1.1 B | 859 M | 770.9 M | 958.2 M |
| TEM | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (209.9 M) | (259.2 M) | (289.8 M) | (214.1 M) | (705.8 M) | (245 M) | (257.3 M) |
| COO | 35.2 M | 248.3 M | 296.2 M | 269.9 M | 203.5 M | 273.9 M | 372.9 M | 139.9 M | 466.7 M | 238.4 M | 2.9 B | 385.8 M | 294.2 M | 392.3 M | 374.9 M | 431.1 M | 452.7 M |
| CNC | (9.4 M) | 111.2 M | 2 M | 165.1 M | 271 M | 355 M | 562 M | 828 M | 900 M | 1.3 B | 1.8 B | 1.3 B | 1.2 B | 2.7 B | 3.3 B | (6.7 B) | (6.3 B) |
| THC | 63 M | 82 M | 152 M | (134 M) | 12 M | (140 M) | (192 M) | (704 M) | 104 M | (215 M) | 399 M | 914 M | 411 M | 611 M | 3.2 B | 1.4 B | 1.5 B |
| NBIX | 5.9 M | 37.6 M | 5 M | (46.1 M) | (60.5 M) | (88.9 M) | (141.1 M) | (142.5 M) | 21.1 M | 37 M | 407.3 M | 89.6 M | 154.5 M | 249.7 M | 341.3 M | 478.6 M | 502.5 M |
Smith Nephew SNATS and related stocks such as Hologic, Zimmer Biomet Holdings, and Fresenius Medical Care Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Smith Nephew SNATS financial statement analysis. It represents the amount of money remaining after all of Smith Nephew SNATS operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Smith Nephew Competitive Analysis
The better you understand Smith Nephew competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Smith Nephew's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Smith Nephew's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Smith Nephew Competition Performance Charts
Five steps to successful analysis of Smith Nephew Competition
Smith Nephew's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Smith Nephew SNATS in relation to its competition. Smith Nephew's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Smith Nephew in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Smith Nephew's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Smith Nephew SNATS, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Smith Nephew position
In addition to having Smith Nephew in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Smith Nephew Correlation with its peers. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Smith diversify its offerings? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Smith Nephew data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.704 | Dividend Share 0.391 | Earnings Share 1.12 | Revenue Per Share | Quarterly Revenue Growth 0.074 |
Understanding Smith Nephew SNATS requires distinguishing between market price and book value, where the latter reflects Smith's accounting equity. The concept of intrinsic value - what Smith Nephew's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Smith Nephew's price substantially above or below its fundamental value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Smith Nephew's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.